Actual Medicinal Product (AMP) Zydol SR 150mg tablets (Mawdsley-Brooks & Company Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Zydol SR 150mg prolonged release tablets (Grunenthal Ltd) and Tramadol Krka 150mg prolonged release tablets (Krka UK Ltd).
- Generic
- Tramadol
- Formulation
- Tramadol 150mg modified-release tablets
-
Tramadol
-
Tramadol 150mg modified-release tablets
-
Zydol SR 150mg tablets (Mawdsley-Brooks & Company Ltd)
-
-
Tramadol 50mg capsules
Tramadol 50mg soluble tablets sugar free
Tramadol 300mg modified-release tablets